✦ LIBER ✦

Bortezomib and Dexamethasone Therapy for Newly Diagnosed Patients With Multiple Myeloma Complicated by Renal Impairment

✍ Scribed by Jian Li; Dao-Bin Zhou; Li Jiao; Ming Hui Duan; Wei Zhang; Yong Qiang Zhao; Ti Shen

Book ID: 115530180
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 673 KB
Volume: 9
Category: Article
ISSN: 1557-9190
DOI: 10.3816/clm.2009.n.077

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with interferon-dexa

Combination therapy with interferon-dexamethasone for newly diagnosed patients with multiple myeloma

✍ Meletios A. Dimopoulos; Donna Weber; Kay B. Delasalle; Raymond Alexanian 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB 👁 1 views

Bortezomib-dexamethasone combination in

Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function

✍ Andrea Nozza; Licia Siracusano; Santoro Armando 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 816 KB

Bortezomib in combination with dexametha

Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: A Chinese experience

✍ Weiyan Zheng; Guoqing Wei; Xiujin Ye; Jingsong He; Li Li; Wenjun Wu; Jimin Shi; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 245 KB

## Objective: Bortezomib-dexamethasone-thalidomide has been reported to be effective in newly-diagnosed multiple myeloma (mm) with an overall response rate of 92% and a cr rate of 18% (alexanian et al, hematology 2007;12(3):235-9), but this regimen has not been tested in the chinese patients. we re

Vincristine, doxorubicin, and dexamethas

Vincristine, doxorubicin, and dexamethasone or thalidomide plus dexamethasone for newly diagnosed patients with multiple myeloma?

✍ Víctor Hugo Jimenez-Zepeda; Virginia Jeanet Domínguez-Martínez 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 619 KB

Stem Cell Mobilization In Patients With

Stem Cell Mobilization In Patients With Newly Diagnosed Multiple Myeloma Following Therapy With Lenalidomide and Dexamethasone

✍ S. Kumar; M.Q. Lacy; A. Dispenzieri; S.R. Hayman; D. Dingli; T. Miceli; M.R. Lit 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Outcomes of patients with multiple myelo

Outcomes of patients with multiple myeloma and renal impairment treated with bortezomib, cyclophosphamide, and dexamethasone without plasma exchange

✍ Luciano J. Costa; Jonathan Abbas; Karen L. Ortiz-Cruz; Yubin Kang; Robert K. Stu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB